Tag: VEITHsymposium
Novel bioabsorbable perivascular wrap aims to reduce AVF failure
As a part of the Novel technologies in haemodialysis access session on the final day of the 2024 VEITHsymposium (19–23 November, New York, USA),...
VEITH audience hears when RCTs are essential for novel vascular access...
As a part of a debate on the last day of the 2024 VEITHsymposium (19–23 November, New York, USA), Robert E Lee, a medical...
Seven key elements for effective compliance for vascular access providers are...
In a recent presentation at the VEITHsymposium 2023 (14–18 November, New York, USA), Terry Litchfield (president, Access Solutions) outlined what she believes to be...
VentureMed to present new data on DCB treatment for PAD
VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...